Health
Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants – News-Medical.Net
A recent study by researchers from Canada aimed to examine the ability of commercial assays to detect vaccine-induced antibodies and recognize the vaccination response….
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) high throughput serology assays have so far been used mainly to conduct seroprevalence studies in large cohorts to help public health decision making.
All recent seroprevalence studies only examined the detection of antibodies from natural SARS-CoV-2 infection. While most of the vaccine candidates produced detectable antibody levels in serological research assays in early phase trials, it is not clear how existing…
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants